Davide Frumento | Molecular Oncology | Best Researcher Award

Prof. Davide Frumento | Molecular Oncology | Best Researcher Award

Adjunct Professor, RomaTre University, Italy

Dr. Davide Frumento is an experienced academic and researcher currently serving as an adjunct professor at Roma Tre University and Milan University in Italy. With a strong background in chemical engineering and biotechnology, he has contributed extensively to the scientific community in various research fields. His multidisciplinary expertise bridges molecular oncology, epigenetics, and biotechnology. Passionate about advancing scientific knowledge, Dr. Frumento has worked in both academic and industry settings, collaborating with top-tier institutions like Harvard University. His research is focused on innovative solutions in health, biotechnology, and environmental sustainability.

Profile

Orcid

Education 

Dr. Davide Frumento holds a PhD in Chemical Engineering from Genoa University (2012-2015), where he specialized in biotechnology applications. He graduated with a BSc and MSc in Biotechnology from the same institution (2005-2011). He further broadened his qualifications with a certification as a Scientific Expert for Criminal Procedures Court of Savona (2024). His academic journey reflects a consistent commitment to advancing his knowledge and skills, particularly in molecular sciences. Throughout his career, Dr. Frumento has continuously expanded his expertise by engaging in postdoctoral research at prominent institutions, including the University of Genoa, Milan University, and Harvard University. His extensive education has laid a strong foundation for his contributions to both academia and the industry.

Experience

Dr. Frumento has a distinguished career in academia and research. Since February 2025, he has served as an adjunct professor at the Penitentiary University Center, Milan University. He also holds a position as an adjunct professor in Epigenetics at Roma Tre University, Italy, since 2021. Previously, he has worked as a postdoctoral researcher at Genoa University, San Raffaele Hospital, and Milan University, where he contributed to research in health sciences and biotechnology. His postdoctoral research has spanned multiple departments, including DISSAL, DIMES, and DIFAR, focusing on various aspects of molecular biology, microbiota, and immunology. Dr. Frumento’s industrial experience includes a role as a Quality Control Microbiology Analyst at Noberasco SpA, further showcasing his diverse professional background. His broad expertise in both academic and industry research makes him a significant contributor to the scientific community.

Awards and Honors

Dr. Frumento’s contributions to the scientific field have earned him several prestigious awards. Notably, in 2021, he received the Smart Cup Scientific Award for Innovation and Technology from Regione Liguria, recognizing his work in health and environmental technology implementation. Earlier, in 2014, he won the Start Cup Scientific Award from the University of Genoa for his innovative work on a microtubular photobioreactor, aimed at improving microalgae culture for commercial use. His dedication to scientific innovation is also reflected in his membership in multiple scientific and technical organizations, including STRA and the Research Data Alliance. Dr. Frumento’s recognition within both the academic and industry sectors highlights his commitment to advancing research in molecular sciences, biotechnology, and environmental sustainability.

Research Focus

Dr. Frumento’s research spans several cutting-edge areas of molecular biology, with particular emphasis on biotechnology, molecular oncology, epigenetics, and environmental sciences. His work on the human microbiota’s role in immune responses and diseases such as hepatitis C and multiple sclerosis has contributed significantly to understanding their interplay. Additionally, he has explored the role of sirtuins in autoimmunity, studying SIRT6 inhibition as a therapeutic strategy for multiple sclerosis and other autoimmune diseases. Dr. Frumento’s research in the application of light-based technologies in immunotherapy further highlights his focus on innovative solutions for health and disease management. His work extends to environmental sustainability, where he investigates biotechnological applications for waste management and bioengineering, particularly in areas such as microalgae culture. By blending molecular biology with practical applications in medicine and the environment, Dr. Frumento continues to push the boundaries of scientific discovery.

Publication Top Notes

  • Interaction Between Human Microbiota, Immune System, and Hepatitis C Virus Infection: A Narrative Review 🦠
  • Light-based technologies in immunotherapy: advances, mechanisms, and applications 💡
  • Effects of Wildfire Exposure on the Human Immune System 🔥🧬
  • Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment 💊
  • Health Technology Assessment (HTA) sull’introduzione di coorti aggiuntive per la vaccinazione contro il meningococco 🦠💉
  • Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration 🧠
  • E-Muser (Enhanced Multiple Sclerosis Expected Rate): A Technical Improvement 🧑‍🔬
  • Sarcoglycanopathies: A Novel Predictive Approach 🧬
  • SIRT6 inhibition as a therapeutic approach for treating multiple sclerosis 🧠💉
  • DAI (Disease Aggressiveness Index) Implementation 📊
  • MuSER (Multiple Sclerosis Expected Rate) Predictive Model Development 🧠📈
  • Gut Microbiota Role in Liver Regeneration 🦠💡
  • Microbiota and HCV Infection Interplay 🦠
  • Oral bacteria contribution in wine flavor perception 🍷🦠
  • The efficacy of the new anti HCV therapy, implementation of a path based on the logic of micro-elimination in the Department of Mental Health and Addictions ASL4 Chiavarese 💊

 

 

Kyeong A So | Gynecologic oncology | Best Researcher Award

Assoc. Prof. Dr. Kyeong A So | Gynecologic oncology | Best Researcher Award

Associate Professor, Konkuk University Hospital, South Korea

Dr. Kyeong A So is an Associate Professor in the Department of Obstetrics and Gynecology at Konkuk University Hospital and School of Medicine, Seoul, Korea. With a distinguished career in gynecologic oncology, Dr. So has contributed significantly to the understanding and treatment of gynecologic cancers. Having earned an M.D., a Master’s degree, and a Ph.D. in Medicine from Korea University, Dr. So’s expertise spans clinical practice, research, and education. They have held various clinical and academic roles, including Assistant Professor and Clinical Professor in prominent hospitals. Dr. So is a leading member of numerous professional organizations such as the Korean Society of Gynecologic Oncology and the Korean Gynecologic Oncology Group. Recognized for their work in both research and education, Dr. So continues to make a remarkable impact in the field through pioneering studies and leadership roles.

Profile

Scopus

Education

Dr. Kyeong A So completed their education at Korea University, Seoul, Korea. They began with the Premedical School from 2000-2002, followed by an M.D. from Korea University School of Medicine (2002-2006). This was followed by advanced postgraduate studies, culminating in a Master of Science degree (2007-2009) and a Doctor of Philosophy (Ph.D.) in Medicine (2009-2012) from Korea University Graduate School. This solid educational foundation has equipped Dr. So with a deep understanding of both clinical and research aspects of gynecologic oncology. Their academic path demonstrates a commitment to continuous learning and advancing medical knowledge, particularly in the field of gynecologic cancer treatment and research.

Experience

Dr. Kyeong A So has an extensive career in both clinical and academic settings. After completing their internship at Seoul National University Hospital (2006-2007), Dr. So trained as a resident at Korea University Guro Hospital, specializing in Obstetrics and Gynecology from 2007-2011. Following residency, they completed a fellowship in Gynecologic Oncology at the same hospital from 2011-2014. Dr. So’s academic journey includes roles as a Clinical Professor at Myongji Hospital (2014-2015) and as an Assistant Professor at Cheil General Hospital and Women’s Healthcare Center (2015-2018). In 2019, they joined Konkuk University Hospital as an Assistant Professor and became an Associate Professor in 2022. In these roles, Dr. So has made significant contributions to medical education, research, and patient care in the field of gynecologic oncology.

Awards and Honors

Dr. Kyeong A So has received several awards and honors in recognition of their excellence in the field of gynecologic oncology. In 2010, they were honored with a Certificate of Commendation from Korea University Medical Center. In 2013, Dr. So received the “Best Oral Abstract” award at the 14th Annual Congress of the Asia-Pacific Association for Gynecologic Endoscopy for their groundbreaking research. Their research has also been widely published and cited, further establishing Dr. So as a leading expert in the field. These accolades reflect Dr. So’s commitment to advancing gynecologic oncology, both through clinical practice and innovative research, and underscore their standing as a respected academic and clinician.

Research Focus

Dr. Kyeong A So’s research focuses on advancing the understanding, diagnosis, and treatment of gynecologic cancers, particularly endometrial and ovarian cancers. They have investigated the molecular and clinical aspects of cancer recurrence, treatment efficacy, and fertility preservation in cancer patients. Dr. So’s work on the impact of menopausal status on HPV infection and vaginal dysbiosis has also contributed to the broader understanding of gynecologic health. Their current research efforts include exploring novel treatment regimens such as immunotherapy and personalized medicine. Through collaboration with international researchers and involvement in clinical trials, Dr. So is committed to improving patient outcomes and providing innovative solutions in the treatment of gynecologic cancers. This work has been widely published, with several articles appearing in high-impact journals, and has garnered significant attention in the scientific community.

Publication Top Notes

  1. Surgical staging in early endometrial cancer without intra-uterine manipulator using the da Vinci SP robotic system 🦠🩺
  2. Risk factors for the recurrence in patients with early endometrioid endometrial cancer achieving complete remission for fertility-sparing hormonal treatment 🔬
  3. Menopausal status induces vaginal dysbiosis in women with human papillomavirus infection 🔬
  4. Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial 📊🧬
  5. The Expression and Amplification of HER2 Has a Significant Impact on the Prognosis of Endometrial Carcinoma in Korean Patients 🧪📑